Again, to provide preliminary indications of the clinical relevance of our identified mechanism of metabolic regulation in cancer involving PROX1, SIRT3, and EZH2, we examined the correlations between these protein expression levels in CRC patient tissues and clinical parameters and prognosis. This evidence concerns the gene PROX1 and colorectal carcinoma.